AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
1.110
-0.060 (-5.13%)
Mar 13, 2026, 4:00 PM EDT - Market closed
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $15.32 million as of March 13, 2026. Its market cap has increased by 1,522.50% in one year.
Market Cap
15.32M
Enterprise Value
27.65M
1-Year Change
1,522.50%
Ranking
Category
Stock Price
$1.11
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $15.32M, a decrease of -75.94%. That is a compound annual growth rate of -25.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 28.09M | 115.68% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | 63.66M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BriaCell Therapeutics | 30.50M |
| Tempest Therapeutics | 30.47M |
| Tiziana Life Sciences | 28.99M |
| Hyperion DeFi | 28.91M |
| CEL-SCI | 28.89M |
| NeuroSense Therapeutics | 28.70M |
| Kyntra Bio | 28.20M |
| Dyadic International | 27.50M |